Sökning: onr:"swepub:oai:DiVA.org:uu-511070" >
Association of beta...
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
-
- Ishak, Divan (författare)
- Uppsala University,Uppsala universitet,Kardiologi,Uppsala Univ, Sweden
-
- Aktaa, Suleman (författare)
- Leeds Teaching Hosp NHS Trust, Dept Cardiol, Leeds, England.;Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Epidemiol & Biostat, Leeds, England,Leeds Teaching Hospitals NHS Trust,Leeds School of Medicine
-
- Lindhagen, Lars (författare)
- Uppsala University,Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala Clin Res Ctr, Sweden
-
visa fler...
-
- Alfredsson, Joakim, 1962- (författare)
- Linköping University,Linköpings universitet,Medicinska fakulteten,Avdelningen för diagnostik och specialistmedicin,Region Östergötland, Kardiologiska kliniken US
-
- Dondo, Tatendashe Bernadette (författare)
- Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Epidemiol & Biostat, Leeds, England,Leeds School of Medicine
-
- Held, Claes (författare)
- Uppsala University,Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala Univ, Sweden; Uppsala Clin Res Ctr, Sweden
-
- Jernberg, Tomas (författare)
- Karolinska Institutet
-
- Yndigegn, Troels (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Hjärtinflammationsforskningsgrupp,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Cardiac Inflammation Research Group,Lund University Research Groups
-
- Gale, Chris P. (författare)
- Leeds Teaching Hosp NHS Trust, Dept Cardiol, Leeds, England.;Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Epidemiol & Biostat, Leeds, England,Leeds School of Medicine,Leeds Teaching Hospitals NHS Trust
-
- Batra, Gorav (författare)
- Uppsala University,Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden.;Uppsala Clin Res Ctr, Uppsala, Sweden.;Uppsala Univ, Dept Med Sci, Cardiol, S-75105 Uppsala, Sweden.
-
visa färre...
-
(creator_code:org_t)
- BMJ Publishing Group Ltd, 2023
- 2023
- Engelska.
-
Ingår i: Heart. - : BMJ Publishing Group Ltd. - 1355-6037 .- 1468-201X. ; 109:15, s. 1159-1165
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://liu.diva-por... (primary) (Raw object)
-
http://dx.doi.org/10... (free)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD).Methods A nationwide cohort study was conducted including 43 618 patients with MI between 2005 and 2016 in the Swedish register for coronary heart disease. Follow-up started 1 year after hospitalisation (index date). Patients with heart failure or LVSD up until the index date were excluded. Patients were allocated into two groups according to BB treatment. Primary outcome was a composite of all-cause mortality, MI, unscheduled revascularisation and hospitalisation for heart failure. Outcomes were analysed using Cox and Fine-Grey regression models after inverse propensity score weighting.Results Overall, 34 253 (78.5%) patients received BB and 9365 (21.5%) did not at the index date 1 year following MI. The median age was 64 years and 25.5% were female. In the intention-to-treat analysis, the unadjusted rate of primary outcome was lower among patients who received versus not received BB (3.8 vs 4.9 events/100 person-years) (HR 0.76; 95% CI 0.73 to 1.04). Following inverse propensity score weighting and multivariable adjustment, the risk of the primary outcome was not different according to BB treatment (HR 0.99; 95% CI 0.93 to 1.04). Similar findings were observed when censoring for BB discontinuation or treatment switch during follow-up.Conclusion Evidence from this nationwide cohort study suggests that BB treatment beyond 1 year of MI for patients without heart failure or LVSD was not associated with improved cardiovascular outcomes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- coronary artery disease
- myocardial infarction
- pharmacology
- clinical
- coronary artery disease
- myocardial infarction
- pharmacology, clinical
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Heart
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Ishak, Divan
-
Aktaa, Suleman
-
Lindhagen, Lars
-
Alfredsson, Joak ...
-
Dondo, Tatendash ...
-
Held, Claes
-
visa fler...
-
Jernberg, Tomas
-
Yndigegn, Troels
-
Gale, Chris P.
-
Batra, Gorav
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Heart
- Av lärosätet
-
Uppsala universitet
-
Linköpings universitet
-
Lunds universitet
-
Karolinska Institutet